Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin

• Sergio Padilla ,

  Contributed equally to this work with: Sergio Padilla, María Andreo

  Roles Conceptualization, Methodology, Writing – original draft

  * E-mail: spadilla@umh.es (SP); marmasiac@gmail.com (MM)

  Affiliations Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spain, CIBER de Enfermedades Infecciosas (CIBERINFEC; Biomedical Research Networking Center for Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain

  https://orcid.org/0000-0002-8420-7310

  ⨯
• María Andreo ,

  Contributed equally to this work with: Sergio Padilla, María Andreo

  Roles Conceptualization, Methodology, Writing – original draft

  Affiliation Internal Medicine Service and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spain

  ⨯
• Pascual Marco,

  Roles Investigation, Writing – review & editing

  Affiliation Hematology Department, Hospital General Universitario Dr. Balmis, Alicante, Spain

  ⨯
• Ana Marco-Rico,

  Roles Investigation, Writing – review & editing

  Affiliation Hematology Department, Hospital General Universitario Dr. Balmis, Alicante, Spain

  ⨯
• Christian Ledesma,

  Roles Formal analysis, Software, Writing – review & editing

  Affiliation Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain

  ⨯
• Marta Fernández-González,

  Roles Data curation, Writing – review & editing

  Affiliations CIBER de Enfermedades Infecciosas (CIBERINFEC; Biomedical Research Networking Center for Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain, Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain

  ⨯
• Javier García-Abellán,

  Roles Writing – review & editing

  Affiliations Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spain, CIBER de Enfermedades Infecciosas (CIBERINFEC; Biomedical Research Networking Center for Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Paula Mascarell,

  Roles Writing – review & editing

  Affiliations Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spain, CIBER de Enfermedades Infecciosas (CIBERINFEC; Biomedical Research Networking Center for Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Ángela Botella,

  Roles Writing – review & editing

  Affiliation Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain

  ⨯
• Félix Gutiérrez,

  Roles Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing

  Affiliations Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spain, CIBER de Enfermedades Infecciosas (CIBERINFEC; Biomedical Research Networking Center for Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Mar Masiá

  Roles Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing

  * E-mail: spadilla@umh.es (SP); marmasiac@gmail.com (MM)

  Affiliations Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spain, CIBER de Enfermedades Infecciosas (CIBERINFEC; Biomedical Research Networking Center for Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain

  ⨯